All In MedTech

FDA Clearance Tracker · P030053-S065

MENTOR MemoryGel Breast Implants

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 8, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 8, 2022

Approved

Time to decision

32 days

Received Feb 4, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030053-S065
Device name
MENTOR MemoryGel Breast Implants
Applicant
Mentor Corp.
Applicant location
Irvin, CA
Received
Feb 4, 2022
Decided
Mar 8, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P030053

Device type

Device class
Class III
Regulation
21 CFR 878.3540

Every decision under product code FTR

FDA's approval statement

As written in FDA's record.

Approval of the revised statistical analysis plan (SAP) for the post-approval study (PAS) referenced above. The SAP has been submitted to align with protocol changes approved in amendment 5 (P030053/S063 and P060028/S042).

Source documents

Other decisions for Mentor Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.